Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Patient safety

Risk of hyperglycaemia for diabetes patients using faulty insulin pens

People with diabetes using insulin pens from a number of faulty batches manufactured by Owen Mumford are at risk of hyperglycaemia, according to an alert issued by the UK medicines regulator.

The fault can cause the dose selector to revert to zero, leading to an under dose of insulin or no insulin at all.

“It is vital that people check if they have these affected pens and should obtain an alternative device before stopping using them,” says Neil McGuire, clinical director of devices for the Medicines and Healthcare products Regulatory Agency (MHRA). “Patients who experience unexpectedly raised blood glucose on self-testing or symptoms of hyperglycaemia, regardless of which insulin delivery device they are using, should contact a healthcare professional immediately if it does not respond to their usual rescue treatment.”

The MHRA says the failure rate of the devices is 42% and people should seek a replacement as soon as possible from the manufacturer Owen Mumford or their pharmacist.

A medical device alert lists the affected batches of Autopen Classic 1 unit pens, Autopen Classic 2 unit pens, Autopen 24 1 unit pens and Autopen 24 unit 2 pens.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067463

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.